These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 22612606)

  • 21. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Women's Health Initiative could not have detected cardioprotective effects of starting hormone therapy during the menopausal transition.
    Naftolin F; Taylor HS; Karas R; Brinton E; Newman I; Clarkson TB; Mendelsohn M; Lobo RA; Judelson DR; Nachtigall LE; Heward CB; Hecht H; Jaff MR; Harman SM;
    Fertil Steril; 2004 Jun; 81(6):1498-501. PubMed ID: 15193467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of Chinese herbal medicines (CHM) on menopausal symptoms compared to hormone replacement therapy (HRT) and placebo.
    Kwee SH; Tan HH; Marsman A; Wauters C
    Maturitas; 2007 Sep; 58(1):83-90. PubMed ID: 17689896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Significant fall in hormone replacement therapy prescription in general practice.
    Lagro-Janssen A; Knufing MW; Schreurs L; van Weel C
    Fam Pract; 2010 Aug; 27(4):424-9. PubMed ID: 20406789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Menopausal symptom management and prevention counseling after the Women's Health Initiative among women seen in an internal medicine practice.
    Schonberg MA; Wee CC
    J Womens Health (Larchmt); 2005; 14(6):507-14. PubMed ID: 16115005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lessons learned from the WHI: HRT requires a cautious and individualized approach.
    Aubuchon M; Santoro N
    Geriatrics; 2004 Nov; 59(11):22-6. PubMed ID: 15615157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should symptomatic menopausal women be offered hormone therapy?
    Lobo RA; Bélisle S; Creasman WT; Frankel NR; Goodman NE; Hall JE; Ivey SL; Kingsberg S; Langer R; Lehman R; McArthur DB; Montgomery-Rice V; Notelovitz M; Packin GS; Rebar RW; Rousseau M; Schenken RS; Schneider DL; Sherif K; Wysocki S
    MedGenMed; 2006; 8(2):1 p preceding 35. PubMed ID: 17048337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and cardiovascular disease revisited.
    Stevenson JC
    Menopause Int; 2009 Jun; 15(2):55-7. PubMed ID: 19465669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hormone therapy for the management of menopausal symptoms: pharmacotherapy update.
    Woodis CB
    J Pharm Pract; 2010 Dec; 23(6):540-7. PubMed ID: 21507860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menopausal hormone replacement therapy.
    Varner RE
    Curr Womens Health Rep; 2003 Oct; 3(5):410-7. PubMed ID: 12959701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Socioeconomic factors in menopausal women's use of hormone replacement therapy.
    Schbley BH
    J Women Aging; 2009; 21(2):99-110. PubMed ID: 19418341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the need to clarify and disseminate contemporary knowledge of hormone therapy initiated near menopause.
    Langer RD
    Climacteric; 2010 Aug; 13(4):303-6. PubMed ID: 20540591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Features and perceptions of menopausal women in Benin City, Nigeria.
    Ande AB; Omu OP; Ande OO; Olagbuji NB
    Ann Afr Med; 2011; 10(4):300-4. PubMed ID: 22064257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormone replacement therapy: real concerns and false alarms.
    Bluming AZ; Tavris C
    Cancer J; 2009; 15(2):93-104. PubMed ID: 19390302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The evidence base for HRT: what can we believe?
    Langer RD
    Climacteric; 2017 Apr; 20(2):91-96. PubMed ID: 28281363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The breast cancer "plunge" after initial publication of the WHI results: an alternative explanation.
    Simon JA; Nahum GG; Stanislaw H; Gaines T
    Maturitas; 2010 Jul; 66(3):277-84. PubMed ID: 20471761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasomotor symptoms in menopause: where we've been and where we're going.
    Pinkerton JV; Zion AS
    J Womens Health (Larchmt); 2006 Mar; 15(2):135-45. PubMed ID: 16536677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current opinions and understandings of menopausal women about hormone replacement therapy (HRT)-the University of Florida experience.
    Levens E; Williams RS
    Am J Obstet Gynecol; 2004 Aug; 191(2):641-6; discussion 646-7. PubMed ID: 15343254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.